GLP-1
‘GLP-1s for Everything!’: Balancing Access With Sustainability
Glucagon-like peptide-1 receptor agonists are moving far beyond their established uses for managing type 2 diabetes ...
AUGUST 16, 2025
GLP-1s Slay Yet Another Condition: Acute Pancreatitis
In a study presented at DDW 2025, GLP-1s appeared to protect patients with chronic pancreatitis from developing ...
AUGUST 15, 2025
Most Patients Can Safely Remain on GLP-1s Before Surgery
Most patients can continue taking GLP-1 receptor agonists before undergoing elective surgery, according to new ...
APRIL 27, 2025
‘A Billion-Dollar Question’ Emerges in GLP-1 Legal Fight
Eli Lilly has sued the FDA over the classification of its investigational GLP-1 drug, retatrutide, arguing that the ...
APRIL 22, 2025
GLP-1 Compounding: Expect Inspections
503A compounding pharmacies can expect more inspections from their state boards of pharmacy and audits from PBMs ...
MARCH 14, 2025
GLP-1 Compounding: Expect Inspections
503A compounding pharmacies can expect more inspections from their state boards of pharmacy and audits from PBMs ...
FEBRUARY 13, 2025
GLP-1 ‘Shadow System’ Of Internet Sellers Poses A Major Safety Concern
Dozens of unscrupulous web-based sellers of glucagon-like peptide-1 agonists are evading FDA scrutiny and patient ...
DECEMBER 16, 2024
Machine Learning Can Predict Best Responders to GLP-1s
Machine learning tools can sift through genetic profiles to predict which patients with obesity will best respond ...
SEPTEMBER 21, 2024
GLP-1RA Use Increases Gastric Food Retention Post-Endoscopy—But Fasting Mitigates This
Although patients appear more likely to retain stomach contents during endoscopic procedures, this risk may ...
MAY 29, 2024
